Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Total Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction (GEJ) and Gastric Cancers: A Pilot Trial

NCT05296005 is registered in ClinicalTrials.gov with Ohio State University Comprehensive Cancer Center as lead sponsor.

NCT NCT05296005
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05296005 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Total Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction (GEJ) and Gastric Cancers: A Pilot Trial
Lead sponsor
Ohio State University Comprehensive Cancer Center
Phase
Phase 1
Overall status
Withdrawn
Start date
December 31, 2025
Completion date
December 31, 2025
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

clinical stage i gastric cancer ajcc v8, clinical stage ii gastric cancer ajcc v8, clinical stage iia gastric cancer ajcc v8, clinical stage iib gastric cancer ajcc v8, clinical stage iib gastroesophageal junction adenocarcinoma ajcc v8, clinical stage iii gastric cancer ajcc v8, clinical stage iii gastroesophageal junction adenocarcinoma ajcc v8, clinical stage iva gastroesophageal junction adenocarcinoma ajcc v8, gastric adenocarcinoma, pathologic stage ib gastric cancer ajcc v8, pathologic stage ic gastroesophageal junction adenocarcinoma ajcc v8, pathologic stage ii gastric cancer ajcc v8, pathologic stage ii gastroesophageal junction adenocarcinoma ajcc v8, pathologic stage iia gastric cancer ajcc v8, pathologic stage iia gastroesophageal junction adenocarcinoma ajcc v8, pathologic stage iib gastric cancer ajcc v8, pathologic stage iib gastroesophageal junction adenocarcinoma ajcc v8, pathologic stage iii gastric cancer ajcc v8, pathologic stage iii gastroesophageal junction adenocarcinoma ajcc v8, pathologic stage iiia gastric cancer ajcc v8, pathologic stage iiia gastroesophageal junction adenocarcinoma ajcc v8, pathologic stage iiib gastric cancer ajcc v8, pathologic stage iiib gastroesophageal junction adenocarcinoma ajcc v8, pathologic stage iiic gastric cancer ajcc v8, pathologic stage iva gastroesophageal junction adenocarcinoma ajcc v8